ISBN: 9780826142061 - the aprn and pa's complete guide to prescribing drug therapy 2024 (10 risultati)

Perfeziona la tua ricerca

  • Libri (10)

a

Fascia di prezzo personalizzata (EUR)

a

  • Lingua: Inglese

    Editore: Springer Publishing Co Inc, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: World of Books (was SecondSale), Montgomery, IL, U.S.A.World of Books (was SecondSale)

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Usato - Buono

    EUR 33,33

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: Good. An unrivaled reference tool for advanced practice providers and students in clinical practice settings This concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice. The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. Purchase includes online access via most mobile devices or computers. New to this Edition: Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases. Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma. Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populations Key Features: Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations. Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions. Serves advanced practice providers across the United States and internationally. Consistent with approvals and recommendations for use by the FDA.…

  • Lingua: Inglese

    Editore: Springer Publishing Co Inc, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: World of Books Inc, Montgomery, IL, U.S.A.World of Books Inc

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Usato - Buono

    EUR 35,18

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: Good. An unrivaled reference tool for advanced practice providers and students in clinical practice settings This concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice. The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. Purchase includes online access via most mobile devices or computers. New to this Edition: Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases. Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma. Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populations Key Features: Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations. Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions. Serves advanced practice providers across the United States and internationally. Consistent with approvals and recommendations for use by the FDA.…

  • Lingua: Inglese

    Editore: Springer Publishing Co Inc, New York, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: Grand Eagle Retail, Bensenville, IL, U.S.A.Grand Eagle Retail

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 74,77

     Spedizione gratuita 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: new. Paperback. An unrivaled reference tool for advanced practice providers and students in clinical practice settingsThis concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice.The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. Purchase includes online access via most mobile devices or computers.New to this Edition:Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases.Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma.Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populationsKey Features:Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations.Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions.Serves advanced practice providers across the United States and internationally.Consistent with approvals and recommendations for use by the FDA. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Lingua: Inglese

    Editore: Springer Publishing Company, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: California Books, Miami, FL, U.S.A.California Books

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 72,01

    EUR 2,69 spedizione 
    Spedito in U.S.A.

    Quantità: Più di 20 disponibili

    Condizione: New.

  • Lingua: Inglese

    Editore: Springer Publishing Company, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: Books From California, Simi Valley, CA, U.S.A.Books From California

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Usato - Molto buono

    EUR 79,59

    EUR 4,47 spedizione 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    paperback. Condizione: Very Good.

  • Lingua: Inglese

    Editore: Springer Publishing Company, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 94,41

    EUR 15,00 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 2 disponibili

    Paperback. Condizione: Brand New. 6th new edition. 750 pages. 9.00x6.00x9.00 inches. In Stock.

  • Lingua: Inglese

    Editore: Springer Publishing Company, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: Books Puddle, Woodside, NY, U.S.A.Books Puddle

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 131,76

    EUR 3,58 spedizione 
    Spedito in U.S.A.

    Quantità: 1 disponibile

    Condizione: New. 6th edition NO-PA16APR2015-KAP.

  • Lingua: Inglese

    Editore: Springer Publishing Company Jan 2024, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 98,20

    EUR 35,00 spedizione 
    Spedito da Germania a U.S.A.

    Quantità: 2 disponibili

    Taschenbuch. Condizione: Neu. Neuware - An unrivaled reference tool for advanced practice providers and students in clinical practice settingsThis concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice.The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. Purchase includes online access via most mobile devices or computers.New to this Edition: - Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases.- Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma.- Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populationsKey Features:- Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations.- Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions.- Serves advanced practice providers across the United States and internationally.- Consistent with approvals and recommendations for use by the FDA.…

  • Lingua: Inglese

    Editore: Springer Publishing Company, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: Majestic Books, Hounslow, Regno UnitoMajestic Books

    Venditore con 4 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 134,51

    EUR 7,80 spedizione 
    Spedito da Regno Unito a U.S.A.

    Quantità: 1 disponibile

    Condizione: New.

  • Lingua: Inglese

    Editore: Springer Publishing Co Inc, New York, 2024

    0826142060 / 9780826142061

    • Brossura

    Da: AussieBookSeller, Truganina, VIC, AustraliaAussieBookSeller

    Venditore con 5 stelle
    Contatta il venditore

    Condizione: Nuovo

    EUR 114,35

    EUR 33,16 spedizione 
    Spedito da Australia a U.S.A.

    Quantità: 1 disponibile

    Paperback. Condizione: new. Paperback. An unrivaled reference tool for advanced practice providers and students in clinical practice settingsThis concise and easy-to-read drug therapy prescribing reference provides critical information for advanced practice nurses and physician assistants in clinical practice settings who are involved in the primary care management of patients with acute, episodic, and chronic health problems, life-altering and life-threatening diseases, and needs for health promotion and disease prevention. Interspersed with clinically useful information, such as monitored laboratory values, patient teaching points, and safety information, this reference draws upon data taken directly from FDA-approved drug labels and patient medication guides, and is organized by diagnosis rather than by drug classification, to provide advanced practice practitioners with the comprehensive, concise, and up-to-date information on drug therapies that they need to help achieve positive outcomes in their daily practice.The first section of this book presents drug treatment regimens for over 700 clinical diagnoses, listed alphabetically by generic name, followed by important information required for prescription decision-making. The second section provides additional information on treatment, organized in a convenient table format. An alphabetical cross-reference index of drugs allows for easy identification of alternate drug names and their location within the text. Purchase includes online access via most mobile devices or computers.New to this Edition:Information on over 100 new diagnoses and over 100 new generic drugs indicated for the treatment of quality of life-altering and life-threatening conditions such as chronic kidney disease, genetic diseases, mesothelioma, MS, metastatic cancers, and rare diseases.Updates on drugs used for site-specific cancers, mental health issues, and commonly diagnosed diseases such as diabetes and asthma.Details on new drug approvals including indications, treatment regimens, adverse reactions, drug-drug interactions, warnings and precautions, and use in special populationsKey Features:Provides new drug treatment regimens for drugs that are first in class, novel drugs, orphan drugs, new drugs with breakthrough or fast track designation and drugs with new indications and expanded social populations.Includes drug prescribing information on diseases prevalent outside of North America, including endemic diseases with known transmission and treatment interventions.Serves advanced practice providers across the United States and internationally.Consistent with approvals and recommendations for use by the FDA. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…